ArticleMolecular therapy. Methods & clinical development2024

A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis.

Brima M Younis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.